Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Pre-ablation endometrial preparation: a comparison between GnRH agonist leuporelin and GnRH antagonist Cetrorelix. A Randomised Controlled Trial.
ISRCTN ISRCTN14156709
ClinicalTrials.gov identifier
Public title Pre-ablation endometrial preparation: a comparison between GnRH agonist leuporelin and GnRH antagonist Cetrorelix. A Randomised Controlled Trial.
Scientific title
Acronym N/A
Serial number at source N0375157911
Study hypothesis To compare the effects of GnRH antagonist Cetrorelix (Cetrocide) and GnRH agonist Leuprorelin (Prostap SR) injections for preoperative endometrial preparation, prior to Transcervical Endometrial Resection (TCRE)
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Transcervical Endometrial Resection (TCRE)
Participants - inclusion criteria 100 eligible women will be identified from those already on the waiting list for Transcervical Endometrial Resection (TCRE).
They will be suitable candidates for the procedure and those with submucous fibroid will not be excluded.
Participants - exclusion criteria 1. Women on hormonal medications within last 3 months
2. Uterine size more than 12 weeks
3. Previous TCRE
Anticipated start date 31/10/2003
Anticipated end date 31/12/2005
Status of trial Completed
Patient information material
Target number of participants 100
Interventions Comparison between GnRH agonist leuporelin and GnRH antagonist Cetrorelix.
Primary outcome measure(s) 1. Endometrial thickness as measured on trans-vaginal ultrasound (sagittal plane) on the day of operation
2. Histological assessment of "endometrial chippings"
3. Comparison of side effect profile
4. Operative difficulties
5. Overall patient satisfaction
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Shrewsbury and Telford Research and Development Consortium (UK)
Trial website
Publications 2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18715405
Contact name Mr  B  Bentick
  Address Shrewsbury & Telford Hospital NHS Trust
Royal Shrewsbury Hospital
Mytton Oak Road
  City/town Shrewsbury
  Zip/Postcode SY3 8XQ
  Country United Kingdom
  Tel +44 (0)1743 261142
  Fax +44 (0)1743 261006
  Email Bernie.Bentick@rsh.nhs.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 01/10/2008
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central